%0 Journal Article
%T Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancy
%A Adrian W Laxton
%A Annette F Carter
%A Fang-Chi Hsu
%A Glenn J Lesser
%A Gregory Russell
%A Kevin High
%A Martha A Alexander-Miller
%A Michael Chan
%A Roy E Strowd
%A Stephen B Tatter
%J Archive of "Neuro-Oncology Practice".
%D 2018
%R 10.1093/nop/npx035
%X For cancer patients, rates of influenza-associated hospitalization and death are 4 times greater than that of the general population. Previously, we reported reduced immunogenicity to the standard-dose influenza vaccine in patients with central nervous system malignancy. In other poorly responding populations (eg, elderly patients), high-dose vaccination has improved efficacy and immunogenicity
%K glioma
%K influenza vaccination
%K immunogenicity
%K lymphopenia
%K vaccination
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655350/